全文获取类型
收费全文 | 809篇 |
免费 | 30篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 14篇 |
妇产科学 | 13篇 |
基础医学 | 46篇 |
口腔科学 | 9篇 |
临床医学 | 77篇 |
内科学 | 83篇 |
皮肤病学 | 11篇 |
神经病学 | 87篇 |
特种医学 | 67篇 |
外科学 | 107篇 |
综合类 | 92篇 |
预防医学 | 24篇 |
眼科学 | 45篇 |
药学 | 74篇 |
中国医学 | 83篇 |
肿瘤学 | 15篇 |
出版年
2024年 | 5篇 |
2023年 | 4篇 |
2022年 | 23篇 |
2021年 | 25篇 |
2020年 | 23篇 |
2019年 | 25篇 |
2018年 | 29篇 |
2017年 | 19篇 |
2016年 | 20篇 |
2015年 | 32篇 |
2014年 | 68篇 |
2013年 | 66篇 |
2012年 | 55篇 |
2011年 | 47篇 |
2010年 | 39篇 |
2009年 | 38篇 |
2008年 | 36篇 |
2007年 | 36篇 |
2006年 | 36篇 |
2005年 | 26篇 |
2004年 | 26篇 |
2003年 | 17篇 |
2002年 | 15篇 |
2001年 | 14篇 |
2000年 | 12篇 |
1999年 | 12篇 |
1998年 | 8篇 |
1997年 | 9篇 |
1996年 | 8篇 |
1995年 | 14篇 |
1994年 | 7篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 4篇 |
1973年 | 5篇 |
1971年 | 5篇 |
1969年 | 5篇 |
1968年 | 2篇 |
排序方式: 共有854条查询结果,搜索用时 15 毫秒
1.
Dissociation of GFAP intermediate filaments in EAE: observations in the lumbar spinal cord 总被引:1,自引:0,他引:1
Acute experimental allergic encephalomyelitis (EAE) in the Lewis rat is a cell-mediated autoimmune disease of central nervous system myelin. The lesion has been characterized by breakdown of the blood-brain barrier, edema, and periventricular infiltration of macrophages and lymphocytes. At the early stage of the disease, the astrocytes show a marked increase in immunostaining for glial fibrillary acidic protein (GFAP). A corresponding increase in GFAP content, however, cannot be demonstrated. Electron microscopic examination of the early lesion shows a typical reactive astrocytic response expressed by an enlarged watery cytoplasm, particularly at the level of the processes surrounding neurons and blood vessels and in the neuropil itself. The astroglial processes contain numerous glycogen particles (aggregates and single particles). Glial filaments are also conspicuous and are arranged in small bundles or loose thin filaments adjacent to the bundles. The glial filaments that normally appear as tight bundles have expanded and appear less dense. We suggest that the increase in GFAP immunostaining of the astrocytes in the early lesion is due in part to edema, which causes dissociation of the filaments and thereby exposes more antigenic sites to the antibodies. 相似文献
2.
腹腔镜治疗腹腔巨大囊肿及术后下身水肿处理(附5例报告) 总被引:1,自引:1,他引:0
目的探讨腹腔镜处理腹腔巨大囊肿及术后下身水肿的方法. 方法 5例腹腔巨大囊肿先行囊肿抽液(1 500~2 000 ml,平均1 800 ml)减压,2例巨大肝囊肿采用经皮穿刺抽液,3例下腹腔囊肿在脐缘小切口直视下抽液,使腹腔空间增大后行腹腔镜下囊肿切除(3例)或开窗引流(2例).对术后出现的下身水肿口服(2例)或静脉注射(3例)利尿剂. 结果 4例术后症状完全消失,1例多囊肝症状明显改善.随访3个月~1年,症状无复发.下身水肿均在5~7 d内基本消失. 结论先行囊肿抽液减压及术后应用小剂量利尿剂可使腹腔巨大囊肿能在腹腔镜下顺利处理并恢复. 相似文献
3.
肺挫伤致肺水肿患者血浆中E-SLT,IL-8,TNF-α和ET-1的变化 总被引:1,自引:1,他引:0
目的本研究观察胸部外伤所致肺水肿病人血中E-选择素、TNF、白细胞介素-8和内皮素的变化.方法用固相双夹心酶联免疫吸附法和放免技术共测定了24例胸部外伤病人在治疗前后血中E-选择素、肿瘤坏死因子、白细胞介素-8和内皮素浓度.结果临床肺水肿病人血中E-选择素、肿瘤坏死因子、白细胞介素-8和内皮素的浓度在发病时明显升高,与正常对照组比较,差异有显著性(P<0.001).治愈后恢复正常,治疗后各项指标与正常对照组比较差异无显著性(P>0.05),但治疗前后差异有显著性(P<0.001).结论E-选择素、肿瘤坏死因子、白细胞介素-8和内皮素在肺水肿发病机制中起着重要,随着这些因子的升高出现肺水肿并逐渐加重,这些因子降低后肺水肿逐步消失.因此对这些因子的检测有助于估计病情和评价疗效. 相似文献
4.
HU-211 is a synthetic, non-psychotropic cannabinoid which acts as a non-competitive NMDA antagonist and antioxidant. We studied the drug's therapeutic window as well as its long-term effect on cognitive and motor functions in a model of closed head injury (CHI) in the rat. A weight-drop device was used to induce CHI in ether anesthetized male rats. HU-211 (5 mg/kg) was administered i.v. to the experimental groups. For the therapeutic window study, drug was injected at 4 or 6 h after CHI. Edema (water content) and clinical status (neurological severity score, NSS) were evaluated at 24 h. Reduction of edema was slight, whereas improvement of NSS was significant when the drug was administered at 4 or 6 h (P = 0.0023and0.059, respectively). To determine the drug's long-term effect, it was administered 1 h after CHI and additional doses were later given. NSS was evaluated for a period of 30 d. A single dose of HU-211 given 1 h post-CHI improved the clinical outcome during the 30 d period (P < 0.01). Repetitive doses of HU-211 injected during the post traumatic period had similar effects. Cognitive functions were evaluated in the Morris water maze, with rats trained either before or after CHI. CHI resulted in a highly significant impairment of these abilities, whereas HU-211 treatment 1 h after CHI improved performance. Our results indicate that HU-211 is a potent cerebroprotective agent, with a therapeutic window of about 4 h. The beneficial response obtained even after a single dose was long lasting, and ameliorated impairment of both motor and cognitive functions following CHI. 相似文献
5.
Correlation between the degree of contrast enhancement and the volume of peritumoral edema in meningiomas and malignant gliomas 总被引:11,自引:1,他引:10
Peritumoral edema and contrast enhancement of brain tumors are both thought to be due to breakdown of the blood-brain barrier
(BBB); however, the exact mechanism by which these two phenomena occur and whether there is a quantitative or etiological
relationship is not known. Our purpose was to determine whether the relationship between the breakdown of the BBB, defined
radiologically as the degree of contrast enhancement, and the volume of surrounding edema is different for high-grade gliomas
and meningiomas. We analyzed 13 meningiomas and 23 gliomas. A direct linear relationship between the degree of contrast enhancement
(dC) and volume of peritumoral edema (V) with a high correlation coefficient (R = 0.66, P = 0.0006) was established for gliomas. A mathematical relationship between dC and V could not be established for meningioma.
The findings for gliomas offer indirect radiological evidence that the defect in the BBB which causes edema is quantitatively
and etiologically related to the defect in the BBB responsible for contrast enhancement. For meningiomas, the lack of a relationship
between dC and V implies either that the mechanisms responsible for formation of edema and contrast enhancement are fundamentally
different or that a physical barrier in certain meningiomas limits propagation of edema into the adjacent white matter.
Received: 4 March 1999 Accepted: 18 March 1999 相似文献
6.
穿地龙对胶原诱发性关节炎关节肿胀率和病理改变作用的研究 总被引:3,自引:0,他引:3
目的 探讨穿地龙对胶原诱导的大鼠关节炎 (CIA)大鼠关节肿胀率和病理改变的作用。方法 用Wistar大鼠建立CIA动物模型 ,用穿地龙水煎剂从造模开始立即灌胃给药 ,时间为 6周 ,用水溶积置换法测量 3周、6周时非注射侧踝关节肿胀率 ,并用苏木素 伊红 (HE)染色方法 ,观察非注射侧踝关节病理组织学改变 ,并进行病理组织学评分。结果 穿地龙水煎剂可减轻CIA大鼠踝关节肿胀率和改善踝关节的病理状态。结论 穿地龙水煎剂对CIA大鼠有治疗作用 相似文献
7.
In order to obtain basic data on the effect of broad-spectrum protease inhibitor against local symptoms of Viperidae snake envenomation, inhibitory capacity of rat murinoglobulin on local hemorrhagic and edematogenic activities of venoms from Crotalus atrox, Bothrops jararaca, Lachesis muta muta, Trimeresurus flavoviridis and Echis carinatus sochureki were examined. Murinoglobulin, pre-incubated with the crude venoms at 37 degrees C for 15 min, inhibited hemorrhagic activity of all five venoms to various extents. The activity of C. atrox was almost completely inhibited at the murinoglobulin/venom ratio (w/w) of 20. The activity of B. jararaca, Lachesis muta muta and T. flavoviridis venoms was considerably inhibited at the ratio of 20 (77.2, 80.0 and 86.2% inhibition, respectively), however some of the activity still remained even at the ratio of 40 (84.2, 79.8 and 86.2% inhibition, respectively). Among the five venoms, E. c. sochureki venom is quite resistant to murinoglobulin treatment and statistically significant inhibition was only found at the ratio of 40 (64.1% inhibition). Fibrinolytic and gelatinase activities were more susceptible to murinoglobulin inhibition. The treatment at the ratios of 10 and 20 almost completely inhibited respectively the fibrinolytic and the gelatinase activities of all the venoms. Murinoglobulin treatment also significantly inhibited the edematogenic activity of L. muta muta, T. flavoviridis and Echis carinatus sochureki. The treatment of murinoglobulin at the ratio of 40 considerably suppressed the swelling up to 60 min after subcutaneous injection of L. muta muta and E. c. sochureki venoms, and up to 30 min after T. flavoviridis venom injection. Murinoglobulin is a potent inhibitor against local effects of multiple snake venoms in Viperidae family. 相似文献
8.
乳腺癌根治术加放射治疗后上肢并发症的临床分析 总被引:5,自引:0,他引:5
目的了解乳腺癌根治手术加放射治疗患者上肢并发症的发病情况及其影响因素。方法对于接受根治或改良根治术后加放射治疗且放射治疗后已超过1年(中位数2.8年)的74例乳腺癌患者,从症状和体征两个方面进行了观测,并应用多因素回归分析相关的发病因素。结果患者上肢水肿的发生率在症状和体征检查中均约为50%,肩关节功能下降分别为49%和58%,患者年龄和全腋窝照射是发生上肢水肿与肩关节运动障碍的独立影响因素。结论上肢水肿和肩关节运动障碍是乳腺癌根治性手术加放射治疗后较常见的并发症,腋窝处理中减少正常组织的损伤以预防或降低其发生率,应该予以高度重视。 相似文献
9.
目的 探讨桃核承气汤治疗老年患者骨折术后肢体水肿并发腹胀、便秘的临床疗效.方法 选取2016年5月—2018年10月收治的112例骨折术后肢体水肿并发腹胀、便秘的老年患者,使用随机数字表法将其随机分为观察组(56例)与对照组(56例).两组均给予常规对症治疗,观察组在此基础上联合桃核承气汤内服治疗,所有患者均治疗7 d... 相似文献
10.
《Saudi Pharmaceutical Journal》2022,30(5):595-604
Anthrax is a zoonotic infection caused by the gram-positive, aerobic, spore-forming bacterium Bacillus anthracis. Depending on the origin of the infection, serious health problems or mortality is possible. The virulence of B. anthracis is reliant on three pathogenic factors, which are secreted upon infection: protective antigen (PA), lethal factor (LF), and edema factor (EF). Systemic illness results from LF and EF entering cells through the formation of a complex with the heptameric form of PA, bound to the membrane of infected cells through its receptor. The currently available anthrax vaccines have multiple drawbacks, and recombinant PA is considered a promising second-generation vaccine candidate. However, the inherent chemical instability of PA through Asn deamidation at multiple sites prevents its use after long-term storage owing to loss of potency. Moreover, there is a distinct possibility of B. anthracis being used as a bioweapon; thus, the developed vaccine should remain efficacious and stable over the long-term. Second-generation anthrax vaccines with appropriate adjuvant formulations for enhanced immunogenicity and safety are desired. In this article, using protein engineering approaches, we have reviewed the stabilization of anthrax vaccine candidates that are currently licensed or under preclinical and clinical trials. We have also proposed a formulation to enhance recombinant PA vaccine potency via adjuvant formulation. 相似文献